PL417238A1 - Device for testing and releasing physiologically active substances - Google Patents

Device for testing and releasing physiologically active substances

Info

Publication number
PL417238A1
PL417238A1 PL417238A PL41723816A PL417238A1 PL 417238 A1 PL417238 A1 PL 417238A1 PL 417238 A PL417238 A PL 417238A PL 41723816 A PL41723816 A PL 41723816A PL 417238 A1 PL417238 A1 PL 417238A1
Authority
PL
Poland
Prior art keywords
testing
active substances
physiologically active
pump
sealed chamber
Prior art date
Application number
PL417238A
Other languages
Polish (pl)
Other versions
PL238239B1 (en
Inventor
Włodzimierz Opoka
Bożena Muszyńska
Jacek Rojowski
Janusz Rumian
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL417238A priority Critical patent/PL238239B1/en
Publication of PL417238A1 publication Critical patent/PL417238A1/en
Publication of PL238239B1 publication Critical patent/PL238239B1/en

Links

Landscapes

  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Przedmiotem wynalazku jest urządzenie do badania uwalniania fizjologicznie aktywnych substancji zawierające szczelną komorę (1), w której wnętrzu umieszczona jest obrotowa podstawa (3) z uchwytem (5) na pojemniki do badania (6) oraz pompa (2) dostarczająca czynnik do szczelnej komory (1), przy czym dysza (7) pompy (2) skierowana jest wylotem na co najmniej jeden pojemnik do badania (6) w taki sposób, że strumień czynnika pompowanego przez pompę (2) zapewnia wprowadzenie obrotowej podstawy (3) w ruch obrotowy, a obrotowa podstawa (3) posiada regulowane nachylenie względem podstawy szczelnej komory (1).The subject of the invention is a device for testing the release of physiologically active substances comprising a sealed chamber (1), in which a rotatable base (3) with a holder (5) for test containers (6) and a pump (2) supplying the medium to the sealed chamber ( 1), where the nozzle (7) of the pump (2) is directed towards the at least one test container (6) in such a way that the stream of medium pumped by the pump (2) ensures the rotation of the rotary base (3) in rotation, and the rotatable base (3) has an adjustable inclination with respect to the sealed chamber base (1).

PL417238A 2016-05-18 2016-05-18 Device for testing and releasing physiologically active substances PL238239B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL417238A PL238239B1 (en) 2016-05-18 2016-05-18 Device for testing and releasing physiologically active substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL417238A PL238239B1 (en) 2016-05-18 2016-05-18 Device for testing and releasing physiologically active substances

Publications (2)

Publication Number Publication Date
PL417238A1 true PL417238A1 (en) 2017-11-20
PL238239B1 PL238239B1 (en) 2021-07-26

Family

ID=60324479

Family Applications (1)

Application Number Title Priority Date Filing Date
PL417238A PL238239B1 (en) 2016-05-18 2016-05-18 Device for testing and releasing physiologically active substances

Country Status (1)

Country Link
PL (1) PL238239B1 (en)

Also Published As

Publication number Publication date
PL238239B1 (en) 2021-07-26

Similar Documents

Publication Publication Date Title
MX2020004171A (en) AEROSOL DELIVERY DEVICE.
AR111741A1 (en) AEROSOL GENERATOR SYSTEM WITH HOUSING
AR101742A1 (en) CALCITONINE AND AMILINE RECEIVER AGONIST
BR112017001427A2 (en) aerosol supply system
CL2018000078A1 (en) Procedures and compositions for diagnosis and for the treatment of adrenoleukodystrophy.
AR106163A1 (en) AEROSOL GENERATOR ITEM THAT HAS A SCATTERED FLAVOR
CL2016003422A1 (en) Lysine specific demethylase-1 inhibitors
EA201891133A1 (en) WATER TUBE
BRPI0918988A2 (en) methods for preserving a vaccine polypeptide and immunogen, and for preparing a vaccine, dry powder, preserved product, sealed vial, ampoule or syringe, use of an excipient, and vaccine.
CL2016003423A1 (en) Lysine specific demethylase-1 inhibitors
WO2015069773A8 (en) Devices and methods for continuous drug delivery via the mouth
BR112017002356A2 (en) liquid formulation compositions, drug delivery devices and methods for preparing and using them
EA201892595A1 (en) NAZAL PHARMACEUTICAL COMPOSITIONS WITH POROUS FILLER
BR112015016634A2 (en) electrical characteristic measuring device
CL2016001918A1 (en) Heteroaryl amides as protein aggregation inhibitors
MX2019001378A (en) SYSTEM TO PREPARE A DRINK.
CL2016002389A1 (en) Compounds derived from amidopyridine, inverse agonist of the cannabinoid receptor type 2 pharmaceutical composition procedure of preparation and use of the compounds in the treatment or prophylaxis of neuropathic pain, asthma, osteoporosis, inflammation, among others.
CL2016002386A1 (en) Ix lyophilized factor formulations.
AR101414A1 (en) PIRROLIDINONE DERIVATIVES AS METAP-2 INHIBITORS
DOP2017000082A (en) PATIENT POSITIONING DEVICE
MX2017010543A (en) DEVICE AND METHOD TO TEST AND INSPECT THE INTEGRITY OF A CONTAINER.
MY180276A (en) Stable liquid formulation of amg 416 (velcalcetide)
EP4461369A3 (en) Aerosolized compositions comprising mitochondria and methods of use thereof
EA201700019A1 (en) HIGHLY PURE ORIENTATION AND METHOD FOR ITS OBTAINING
BR112017010364A2 (en) device for checking the sharpness of an annular blade